Suppr超能文献

与非侵入性产前检测相关的伦理、法律和社会问题(ELSI):对产前诊断和生殖选择演变的思考。

Ethical, Legal and Social Issues (ELSI) Associated with Non-Invasive Prenatal Testing: Reflections on the Evolution of Prenatal Diagnosis and Procreative Choices.

机构信息

Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

Molecular Diagnosis and Characterization of Pathogenic Mechanisms of Rare Genetic Diseases, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy.

出版信息

Genes (Basel). 2021 Jan 30;12(2):204. doi: 10.3390/genes12020204.

Abstract

New technologies such as non-invasive prenatal testing (NIPT), capable of analyzing cell-free fetal DNA in the maternal bloodstream, have become increasingly widespread and available, which has in turn led to ethical and policy challenges that need addressing. NIPT is not yet a diagnostic tool, but can still provide information about fetal genetic characteristics (including sex) very early in pregnancy, and there is no denying that it offers valuable opportunities for pregnant women, particularly those at high risk of having a child with severe genetic disorders or seeking an alternative to invasive prenatal testing. Nonetheless, the ethical, legal and social implications (ELSI) include multiple aspects of informed decision-making, which can entail risks for the individual right to procreative autonomy, in addition to the potential threats posed by sex-selective termination of pregnancy (in light of the information about fetal sex within the first trimester), and the stigmatization and discrimination of disabled individuals. After taking such daunting challenges into account and addressing NIPT-related medicolegal complexities, the review's authors highlight the need for an ethically and legally sustainable framework for the implementation of NIPT, which seems poised to become a diagnostic tool, as its scope is likely to broaden in the near future.

摘要

新技术如非侵入性产前检测(NIPT),能够分析母体血液中的游离胎儿 DNA,已经越来越普及,这也带来了需要解决的伦理和政策挑战。NIPT 目前还不是一种诊断工具,但仍然可以在怀孕早期提供有关胎儿遗传特征(包括性别)的信息,而且不可否认,它为孕妇提供了宝贵的机会,特别是那些有生育严重遗传疾病孩子风险的孕妇,或者寻求替代侵入性产前检测的孕妇。然而,其伦理、法律和社会影响(ELSI)包括知情决策的多个方面,这可能会对个人的生殖自主权利带来风险,除此之外,还可能存在因胎儿性别信息而导致的妊娠选择性终止(在孕早期)的威胁,以及对残疾个体的污名化和歧视。在考虑到这些令人望而生畏的挑战并解决与 NIPT 相关的医学法律复杂性之后,审查的作者强调了需要为 NIPT 的实施建立一个在伦理和法律上可持续的框架,因为 NIPT 似乎即将成为一种诊断工具,因为它的范围可能在不久的将来扩大。

相似文献

6
From late fatherhood to prenatal screening of monogenic disorders: evidence and ethical concerns.
Hum Reprod Update. 2021 Oct 18;27(6):1056-1085. doi: 10.1093/humupd/dmab023.
7
Prenatal screening for fetal aneuploidy in singleton pregnancies.
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
8
Noninvasive Prenatal Genetic Testing: Current and Emerging Ethical, Legal, and Social Issues.
Annu Rev Genomics Hum Genet. 2015;16:369-98. doi: 10.1146/annurev-genom-090314-050000.
9
Prenatal screening: current practice, new developments, ethical challenges.
Bioethics. 2015 Jan;29(1):1-8. doi: 10.1111/bioe.12123.
10
Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Adv Clin Chem. 2016;74:63-102. doi: 10.1016/bs.acc.2015.12.004. Epub 2016 Jan 21.

引用本文的文献

1
Healthcare professionals' perspectives on and experiences with non-invasive prenatal testing: a systematic review.
Hum Genet. 2025 Apr;144(4):343-374. doi: 10.1007/s00439-025-02736-y. Epub 2025 Apr 9.
2
Towards a Responsible Implementation of NIPT as a First-Tier Test in Canada: Decision-Makers' Perspectives.
Prenat Diagn. 2025 Apr;45(4):453-463. doi: 10.1002/pd.6753. Epub 2025 Jan 31.
4
CffDNA screening for Niemann-pick disease, type C1: a case series.
Front Med (Lausanne). 2024 Aug 5;11:1390693. doi: 10.3389/fmed.2024.1390693. eCollection 2024.
5
Policy Guidance for Direct-to-Consumer Genetic Testing Services: Framework Development Study.
J Med Internet Res. 2024 Jul 17;26:e47389. doi: 10.2196/47389.
6
Non-Invasive Prenatal Testing (NIPT): Reliability, Challenges, and Future Directions.
Diagnostics (Basel). 2023 Aug 2;13(15):2570. doi: 10.3390/diagnostics13152570.
7
Attitudes toward Medical Ethics among Obstetricians and Gynecologists in Saudi Arabia: An Exploratory Survey.
Healthcare (Basel). 2023 May 11;11(10):1394. doi: 10.3390/healthcare11101394.

本文引用的文献

1
Y RNA: An Overview of Their Role as Potential Biomarkers and Molecular Targets in Human Cancers.
Cancers (Basel). 2020 May 14;12(5):1238. doi: 10.3390/cancers12051238.
2
Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation.
Acta Obstet Gynecol Scand. 2020 Jun;99(6):722-730. doi: 10.1111/aogs.13841. Epub 2020 Apr 3.
5
An ethical framework for genetic counseling in the genomic era.
J Genet Couns. 2020 Oct;29(5):718-727. doi: 10.1002/jgc4.1207. Epub 2019 Dec 19.
6
Cell-free nucleic acids in prenatal diagnosis and pregnancy-associated diseases.
EJIFCC. 2019 Jun 24;30(2):215-223. eCollection 2019 Jun.
8
Mothers of a child with Down syndrome: A qualitative analysis of the perspectives on non-invasive prenatal testing.
Midwifery. 2019 Sep;76:118-124. doi: 10.1016/j.midw.2019.06.001. Epub 2019 Jun 4.
10
Looking into the shadow: the eugenics argument in debates on reproductive technologies and practices.
Monash Bioeth Rev. 2018 Dec;36(1-4):1-22. doi: 10.1007/s40592-018-0086-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验